December 2, 2005 -- Looking for a stock that outperformed Amgen and Genentech over the past 2 years? Look no further than Ventiv Health, a provider of outsourced sales and marketing solutions for pharma, biotech and life sciences. It may not sound as sexy as making drugs, but as those new drugs are launched and pharma-biotech sales go up, so goes Ventiv. We look at what is going on with Ventiv and what it would add to a biotech portfolio...
